0001375151-19-000024.txt : 20190308
0001375151-19-000024.hdr.sgml : 20190308
20190308164823
ACCESSION NUMBER: 0001375151-19-000024
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190306
FILED AS OF DATE: 20190308
DATE AS OF CHANGE: 20190308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TANNENBAUM RENEE P
CENTRAL INDEX KEY: 0001543174
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34962
FILM NUMBER: 19669752
MAIL ADDRESS:
STREET 1: 9220 KIRBY DRIVE
STREET 2: SUITE 500
CITY: HOUSTON
STATE: TX
ZIP: 77054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZOGENIX, INC.
CENTRAL INDEX KEY: 0001375151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205300780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 550-8300
MAIL ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: ZOGENIX INC
DATE OF NAME CHANGE: 20060911
4
1
wf-form4_155208168912225.xml
FORM 4
X0306
4
2019-03-06
0
0001375151
ZOGENIX, INC.
ZGNX
0001543174
TANNENBAUM RENEE P
C/O ZOGENIX, INC.
5959 HORTON STREET, SUITE 500
EMERYVILLE
CA
94608
1
0
0
0
Common Stock
2019-03-06
4
M
0
9375
10.40
A
19375
D
Common Stock
2019-03-06
4
M
0
6000
12.80
A
25375
D
Common Stock
2019-03-06
4
M
0
20000
12.75
A
45375
D
Common Stock
2019-03-06
4
M
0
20000
8.99
A
65375
D
Common Stock
2019-03-06
4
S
0
17503
50.647
D
47872
D
Stock Option (Right to Buy)
10.4
2019-03-06
4
M
0
9375
0
D
2025-02-05
Common Stock
9375.0
0
D
Stock Option (Right to Buy)
12.8
2019-03-06
4
M
0
6000
0
D
2025-06-17
Common Stock
6000.0
3000
D
Stock Option (Right to Buy)
8.99
2019-03-06
4
M
0
20000
0
D
2026-07-12
Common Stock
20000.0
0
D
Stock Option (Right to Buy)
12.75
2019-03-06
4
M
0
20000
0
D
2027-05-22
Common Stock
20000.0
0
D
The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $50.40 to $50.90, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option was granted on February 6, 2015, which is the vesting commencement date. Shares subject to the option vests over three years in thirty-six equal monthly installments, subject to the Reporting Person's continued service to the Company on each vesting date.
The option was granted on June 18, 2015 and vests in a series of twelve (12) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
The option was granted on July 13, 2016 and vests in a series of twelve (12) successive, equal monthly installments, on the first day of each calendar month following the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
The option was granted on May 23, 2017, the date of the Company's Annual Meeting of Stockholders, and vests in a series of twelve (12) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
/s/ Thomas Doyle, Attorney-in-fact for Renee P. Tannenbaum
2019-03-08